Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22711,96,1.13 [0.82-1.56],0.4422604370506288
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23324,173,1.00 [0.78-1.27],0.9907499518859822
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23098,1131,1.10 [1.00-1.21],0.0400576756321219
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,23348,407,1.03 [0.88-1.21],0.7120997179890024
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22621,2949,1.07 [1.01-1.13],0.0296193121402591
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22836,2413,1.06 [0.99-1.13],0.0774194476885689
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23114,1143,1.12 [1.02-1.22],0.0199697819479907
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23256,76,1.14 [0.79-1.63],0.480340020869325
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21808,671,1.08 [0.96-1.23],0.1920433133369475
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21078,775,1.10 [0.98-1.23],0.098146169952096
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,21123,214,1.06 [0.85-1.32],0.601584594637056
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16352,1382,1.13 [1.03-1.23],0.0064084011277166
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20938,315,1.22 [1.02-1.45],0.0291494702625667
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23296,1325,1.10 [1.01-1.20],0.0365756437767613
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Mycoses,23399,458,1.06 [0.92-1.23],0.4243395606202113
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22766,799,1.14 [1.02-1.27],0.0218177593155807
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23353,738,1.10 [0.98-1.24],0.0968262071142667
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22144,173,1.00 [0.79-1.28],0.9826412622389458
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23457,37,1.37 [0.83-2.25],0.2204959730935717
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23267,652,1.09 [0.96-1.23],0.1907829302508588
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23254,74,0.96 [0.66-1.39],0.8237621174348679
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23372,163,1.29 [1.02-1.64],0.0349410775910424
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23358,149,1.24 [0.97-1.60],0.0900282126759026
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22250,283,1.07 [0.89-1.29],0.4732436472770245
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22192,225,1.03 [0.83-1.27],0.7837068452382474
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22071,100,1.45 [1.07-1.96],0.0151452023272743
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23434,32,1.11 [0.64-1.92],0.7207584700674914
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23390,139,0.98 [0.75-1.28],0.8817149645095667
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Viral warts,23290,39,0.84 [0.50-1.41],0.5044828104504313
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23321,70,1.04 [0.71-1.51],0.8510855794403834
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Benign lipomatous neoplasm,23214,200,1.00 [0.80-1.25],0.989387566722884
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23365,57,1.26 [0.84-1.88],0.2657677806345832
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23358,58,1.10 [0.73-1.65],0.6627603073815562
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23204,1028,1.03 [0.94-1.14],0.5268900050737982
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Benign neoplasm of meninges,23433,74,1.12 [0.78-1.62],0.5265105765670375
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23399,58,0.93 [0.61-1.42],0.7302092365764696
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23426,114,1.11 [0.83-1.49],0.4929696558279947
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Benign neoplasm of ovary,23387,148,1.08 [0.84-1.40],0.5412640817472849
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23437,230,0.95 [0.77-1.18],0.642704080308774
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Benign neoplasm: Caecum,23444,212,0.92 [0.74-1.15],0.4479064187678817
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23377,56,0.95 [0.61-1.46],0.801439613934449
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,23442,130,0.78 [0.58-1.04],0.0915323720783005
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Benign neoplasm: Rectum,23403,237,0.97 [0.78-1.19],0.7426429000738131
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23357,427,1.08 [0.93-1.26],0.3206847218060611
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23442,244,0.95 [0.78-1.17],0.6540779681995245
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Carcinoma in situ of breast,19003,118,0.72 [0.53-0.97],0.032522761872367
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19073,136,0.90 [0.69-1.19],0.4802672495738374
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",19070,31,0.96 [0.54-1.72],0.8899348525022928
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",19095,56,1.26 [0.83-1.91],0.2827765044838988
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23396,123,1.07 [0.81-1.42],0.6416905808000513
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Haemangioma, any site",23397,121,1.06 [0.80-1.41],0.6867261331920148
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Leiomyoma of uterus,22605,487,0.95 [0.82-1.09],0.4466730641548819
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Lung cancer and mesothelioma,16845,271,0.95 [0.78-1.16],0.6118389400424429
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Lymphoid leukaemia,19072,33,1.11 [0.64-1.94],0.7016129204890411
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19191,152,1.00 [0.77-1.29],0.9819075518873386
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",19133,94,1.14 [0.83-1.58],0.4161740499592417
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19204,165,0.79 [0.61-1.03],0.0767892051402662
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",19099,60,1.34 [0.90-2.00],0.1462610151891782
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",19100,61,1.24 [0.83-1.85],0.2879428502022257
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",19088,49,1.32 [0.85-2.05],0.216986560650461
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19161,122,1.04 [0.78-1.40],0.7678178091740071
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",19128,89,1.20 [0.86-1.67],0.286105746275252
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",19110,71,1.18 [0.81-1.72],0.3774499178573139
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",19073,34,1.20 [0.70-2.05],0.5090305478182908
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,19109,70,0.82 [0.55-1.21],0.3111307701430859
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Melanocytic naevi,23230,204,1.24 [1.00-1.54],0.0456538757805046
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Melanocytic naevi of trunk,23421,69,1.17 [0.80-1.69],0.4196998667598443
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Melanoma in situ,19066,75,0.95 [0.65-1.38],0.7754384331176545
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",19108,69,1.28 [0.88-1.86],0.1914918683252012
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19168,129,1.42 [1.09-1.86],0.0097673089883283
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",19240,201,0.83 [0.66-1.04],0.1105368188653477
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",19119,80,1.48 [1.06-2.07],0.0222841152887914
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Other benign neoplasms of skin,23264,149,1.08 [0.83-1.39],0.5656071034485162
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19827,788,1.01 [0.90-1.13],0.8693304259772712
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19862,823,1.00 [0.89-1.12],0.9928835368712392
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23184,330,1.05 [0.89-1.25],0.5518981258919733
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21758,83,0.95 [0.66-1.36],0.7709927104278
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22922,68,1.52 [1.06-2.17],0.0222715176279922
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22589,2521,1.16 [1.09-1.23],5.106544533271183e-06
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22086,27,1.19 [0.65-2.17],0.5798235307093876
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23115,43,2.15 [1.42-3.26],0.0003175463931539
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22956,1281,1.18 [1.09-1.29],0.0001359849905439
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22956,1281,1.18 [1.09-1.29],0.0001359849905439
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21741,66,0.93 [0.62-1.38],0.7116303247335574
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23107,1048,1.28 [1.16-1.40],4.3525828884477124e-07
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23173,101,1.08 [0.79-1.47],0.6418204815689302
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22897,43,1.17 [0.73-1.89],0.5114548823090823
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22906,52,1.27 [0.83-1.94],0.2702499987579215
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23270,198,1.08 [0.87-1.36],0.480997351553052
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23362,53,1.44 [0.96-2.16],0.0791890051053595
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23240,168,0.83 [0.64-1.06],0.1381145170728304
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22171,112,1.13 [0.84-1.52],0.4126100494599682
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,18899,203,0.93 [0.74-1.17],0.5359545673881001
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22241,55,1.07 [0.68-1.69],0.7542728528468866
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22240,54,1.24 [0.80-1.93],0.3423741687058071
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,18739,43,1.51 [0.96-2.39],0.0755658340298286
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21525,53,1.04 [0.67-1.61],0.8560231555150717
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21225,210,1.06 [0.85-1.32],0.5973133715488554
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23084,405,0.98 [0.83-1.15],0.7845891446646698
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22931,252,0.98 [0.80-1.20],0.8398953539493229
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22737,58,1.40 [0.94-2.08],0.098964984510078
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23133,1661,1.03 [0.95-1.11],0.4691644092072169
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,20803,1624,1.04 [0.96-1.12],0.3890736890598469
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",18743,47,1.14 [0.72-1.80],0.5831681068834058
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",20854,101,1.14 [0.84-1.56],0.3972652914076682
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,18940,244,1.16 [0.95-1.43],0.1392446324372232
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,18737,41,1.45 [0.91-2.32],0.1180549569122613
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21378,2682,1.06 [1.00-1.13],0.0552738584623234
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,18876,180,1.00 [0.78-1.27],0.9898479916012008
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,19165,469,1.18 [1.02-1.37],0.022131860567913
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23375,306,1.23 [1.03-1.47],0.0214885057699992
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23212,143,1.35 [1.05-1.74],0.019604779128984
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,18784,88,1.36 [0.98-1.88],0.0635493393454703
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",18745,49,1.08 [0.69-1.71],0.7266275012056116
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22710,1957,1.12 [1.04-1.20],0.002157387694551
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,18867,171,0.88 [0.68-1.13],0.3107796769669937
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,18864,168,1.23 [0.97-1.57],0.0935448364073428
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19153,457,1.06 [0.91-1.23],0.4457338683935278
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,18764,68,1.09 [0.74-1.60],0.6736937360173999
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23206,137,1.25 [0.96-1.63],0.0973011404622417
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,19220,524,1.01 [0.87-1.16],0.9228560979498444
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,19169,473,1.08 [0.94-1.25],0.2796102546984297
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21077,62,1.08 [0.73-1.61],0.7009445798921701
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22707,4011,1.07 [1.02-1.12],0.0092895401148743
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,20815,62,0.84 [0.55-1.27],0.401152712904272
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,20830,77,1.16 [0.82-1.66],0.3990258702073855
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23294,1758,0.98 [0.91-1.06],0.6014488667193039
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23298,1757,0.98 [0.91-1.06],0.5845896029441568
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,20824,71,1.08 [0.74-1.58],0.6762334822032112
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23104,1348,1.10 [1.01-1.19],0.0365742992879746
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",19971,1275,1.04 [0.95-1.14],0.4023624662832964
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23448,152,1.04 [0.80-1.35],0.7755379894195382
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22720,41,1.49 [0.93-2.38],0.0996075264032638
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,21871,115,0.82 [0.61-1.12],0.2107811846290395
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,21924,168,1.03 [0.81-1.32],0.7999657484777689
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",18910,214,1.26 [1.02-1.56],0.0341634823667949
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,21901,118,1.13 [0.85-1.51],0.3958491345542259
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1448,37,0.77 [0.43-1.36],0.3682857609440535
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1541,149,1.17 [0.90-1.52],0.2284594978833321
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,21807,24,1.30 [0.69-2.47],0.4170309255209457
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1432,22,0.74 [0.36-1.52],0.4080257876036943
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23053,1270,1.05 [0.96-1.15],0.2561057602943398
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22964,285,0.91 [0.75-1.10],0.3272792781505018
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21427,412,1.06 [0.91-1.24],0.4504309023488211
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19302,606,1.13 [0.99-1.29],0.0617735498961003
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23371,206,0.92 [0.74-1.15],0.4762324188874588
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22573,45,1.17 [0.74-1.87],0.504401928972793
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Angina pectoris,22158,729,1.03 [0.91-1.16],0.639190191073317
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22609,81,1.05 [0.74-1.50],0.7689773737043661
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22558,30,1.34 [0.77-2.35],0.2994064600084907
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22666,138,1.01 [0.77-1.33],0.9205102631896048
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,15241,1238,1.01 [0.92-1.11],0.8210864951918805
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,AV-block,20580,205,0.93 [0.74-1.17],0.5352492146876948
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23415,260,0.84 [0.69-1.03],0.0958912579933464
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,14109,106,1.27 [0.94-1.71],0.1244835688158191
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,20495,120,0.73 [0.54-0.99],0.0402145947744899
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",20448,73,0.85 [0.58-1.25],0.4129134449901578
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23454,26,0.52 [0.27-0.99],0.0469144513865062
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Conduction disorders,20994,619,1.07 [0.95-1.22],0.2705766422606044
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22681,1261,1.02 [0.93-1.12],0.6520481220685208
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21106,6213,1.03 [0.99-1.07],0.1472654438534517
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22181,219,1.01 [0.82-1.26],0.9158043709637756
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Endocarditis,20420,45,1.02 [0.63-1.65],0.9309640660196818
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23375,706,1.13 [1.01-1.28],0.0392275829013319
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Hypertension,21636,5222,1.02 [0.98-1.07],0.3203900013415678
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21644,5230,1.02 [0.98-1.07],0.3082799574068671
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23359,34,0.62 [0.34-1.10],0.102903824676458
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16562,148,0.89 [0.68-1.16],0.374043747533902
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16479,65,0.92 [0.62-1.37],0.6810948916946158
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Hypotension,23342,907,0.91 [0.82-1.02],0.0933110075422628
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22820,81,1.05 [0.74-1.49],0.7982768304579757
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22855,1426,1.03 [0.95-1.12],0.4448060261682243
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23192,382,1.05 [0.89-1.23],0.567939557069637
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,20637,262,1.13 [0.93-1.38],0.2062375732439181
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23271,517,1.06 [0.92-1.22],0.4156603716821049
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",21846,417,1.11 [0.95-1.30],0.1785074861278275
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23433,76,1.28 [0.90-1.82],0.1697638829902266
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23449,209,1.09 [0.88-1.36],0.4249069329985873
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,21995,33,0.71 [0.40-1.27],0.2533016226180482
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Other aneurysm,22578,50,0.68 [0.42-1.08],0.104526753523865
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,20680,305,1.11 [0.92-1.32],0.2737777417198761
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22589,61,1.42 [0.96-2.09],0.0805239413942241
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22701,173,1.19 [0.94-1.50],0.1570979431334983
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,20521,146,0.95 [0.73-1.24],0.7203248125728783
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,22037,75,1.06 [0.74-1.53],0.7504557331412152
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22003,41,1.16 [0.71-1.88],0.5567657353703125
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22403,32,0.48 [0.26-0.88],0.0173010264151559
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22092,130,0.83 [0.62-1.11],0.2042322392391411
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21040,665,1.03 [0.91-1.17],0.6495447406636414
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22472,37,0.59 [0.34-1.03],0.0650459620400272
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22968,440,0.97 [0.83-1.13],0.7118400668389759
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22957,278,0.97 [0.80-1.18],0.7717134523268001
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22824,453,0.97 [0.84-1.13],0.7086857820818546
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14251,248,1.07 [0.88-1.31],0.489202401184022
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22761,243,0.96 [0.78-1.18],0.697714146800964
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22246,284,1.08 [0.89-1.30],0.4376427667191781
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23056,377,1.09 [0.92-1.28],0.3142250255963655
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23387,491,0.97 [0.84-1.12],0.694399902445751
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,20557,182,1.15 [0.91-1.46],0.2281263640315028
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22951,272,1.00 [0.82-1.21],0.9644539397503124
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22501,130,0.84 [0.63-1.12],0.2425710990532895
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23183,444,1.06 [0.91-1.23],0.481340938300109
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23161,484,1.04 [0.90-1.20],0.5732176720062685
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22793,61,1.11 [0.74-1.66],0.6063279942083966
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,22564,36,1.29 [0.78-2.15],0.3211530422480247
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22987,177,1.27 [1.01-1.60],0.0407942695698814
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22925,171,1.05 [0.83-1.35],0.6731404549390898
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Varicose veins,22335,373,1.00 [0.85-1.18],0.9840461724469663
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,22538,82,0.68 [0.47-0.99],0.0442438371211358
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23273,599,1.09 [0.96-1.24],0.1830582629895033
PMM2,Phosphomannomutase 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23420,192,1.11 [0.89-1.39],0.3536238941994487
PMM2,Phosphomannomutase 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20862,1575,1.08 [1.00-1.17],0.054562300812995
PMM2,Phosphomannomutase 2,Chapter V Mental and behavioural disorders,Any mental disorder,22951,3664,1.05 [0.99-1.10],0.1005748025639098
PMM2,Phosphomannomutase 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23394,224,1.05 [0.85-1.30],0.6325634302600815
PMM2,Phosphomannomutase 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20964,1677,1.04 [0.96-1.12],0.3526509725279152
PMM2,Phosphomannomutase 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19364,77,0.99 [0.68-1.42],0.9361601417076352
PMM2,Phosphomannomutase 2,Chapter V Mental and behavioural disorders,Smoking dependency,23110,1015,1.09 [0.98-1.20],0.1169444127262571
PMM2,Phosphomannomutase 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20461,1174,1.07 [0.98-1.18],0.1273848210295395
PMM2,Phosphomannomutase 2,Chapter V Mental and behavioural disorders,Vascular dementia,23043,91,0.85 [0.60-1.20],0.3541122230597333
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Alzheimer disease,23455,313,1.03 [0.86-1.24],0.7396635950935349
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",16087,51,0.95 [0.60-1.51],0.8271847945007511
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Bell's palsy,21631,72,0.79 [0.54-1.16],0.2317627634960011
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22097,538,0.94 [0.82-1.08],0.3523529281903785
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Cerebral cysts,23111,187,1.16 [0.93-1.46],0.1960193873256953
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23393,229,0.85 [0.69-1.06],0.1525927915267838
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23046,36,1.23 [0.74-2.06],0.4284797731387956
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23444,43,1.33 [0.84-2.11],0.2297908841967468
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22969,45,0.93 [0.57-1.50],0.754055010222221
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Epilepsy,22212,236,0.96 [0.78-1.19],0.7240403482540587
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23095,1119,1.04 [0.94-1.14],0.4356048927914727
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23412,300,1.04 [0.87-1.25],0.6694605420842545
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22923,2449,0.97 [0.91-1.04],0.3771201800894275
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,23147,40,1.79 [1.14-2.79],0.0111241621401117
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Hemiplegia,23346,182,0.94 [0.74-1.19],0.6100693538371088
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Hydrocephalus,22980,56,1.23 [0.82-1.86],0.3121762855160321
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23438,67,1.34 [0.93-1.94],0.1219319763487428
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21665,106,0.93 [0.68-1.26],0.6271539136559203
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21614,55,1.23 [0.82-1.87],0.3207845666966676
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Memory loss,22935,92,0.95 [0.68-1.33],0.7689170636981127
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Migraine,22409,433,1.07 [0.92-1.25],0.3529908442058405
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23359,393,1.07 [0.91-1.25],0.4086305347103305
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Motor neuron disease,16172,112,1.21 [0.90-1.63],0.2040420343199712
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23264,121,0.97 [0.73-1.29],0.8387838567014381
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22743,1184,0.95 [0.87-1.04],0.2762457359644951
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Neurological diseases,22071,3143,1.02 [0.96-1.08],0.5632592245639121
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23132,122,1.11 [0.84-1.48],0.464709008494531
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21920,361,0.93 [0.79-1.10],0.4174802053436991
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23408,196,1.13 [0.91-1.42],0.271573242417217
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18981,558,1.03 [0.90-1.18],0.6861979786630328
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22981,57,1.05 [0.69-1.59],0.8346731560532766
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23032,108,0.99 [0.73-1.35],0.9732272598243042
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23251,139,0.93 [0.71-1.23],0.6187522458630978
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21639,80,0.80 [0.55-1.15],0.23008714169261
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Other headache syndromes,22045,69,1.30 [0.90-1.88],0.1567274093024684
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Other neurological diseases,23353,429,1.12 [0.97-1.31],0.1318548003450088
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Other sleep disorders,22312,336,0.87 [0.73-1.04],0.1347204198580822
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Parkinson's disease,23433,141,1.03 [0.79-1.35],0.8347813394551048
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22995,71,1.36 [0.95-1.94],0.0895955238104444
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,23454,75,0.94 [0.65-1.36],0.7353049259175534
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Sleep apnoea,23306,272,0.87 [0.71-1.06],0.1631424623480492
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23245,33,1.29 [0.76-2.20],0.3524226017978784
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23445,136,0.99 [0.75-1.30],0.9299077073331832
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21616,57,0.94 [0.61-1.44],0.7621050822493448
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23455,316,1.03 [0.86-1.24],0.7250096728865125
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23004,88,0.82 [0.58-1.17],0.2774316261828127
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22943,93,0.98 [0.70-1.36],0.8822045643467443
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23064,423,1.08 [0.92-1.26],0.3370881797403281
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23331,141,1.03 [0.79-1.35],0.8147883221091191
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22502,51,0.99 [0.63-1.55],0.9694337269888542
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22498,47,1.28 [0.82-1.99],0.2781903410889622
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23344,55,1.16 [0.76-1.77],0.4966520712262043
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23214,148,1.02 [0.79-1.33],0.8582240378016704
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1439,28,0.97 [0.52-1.81],0.9250908502182832
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1727,54,0.77 [0.48-1.22],0.2628372449576973
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22934,84,0.92 [0.64-1.30],0.6266769135355776
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23307,896,1.13 [1.02-1.26],0.0219514264413322
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23093,642,1.02 [0.90-1.15],0.8062941952897235
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22709,258,0.99 [0.82-1.21],0.9576110008770342
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23380,739,1.01 [0.90-1.14],0.8087448388909442
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23443,62,1.21 [0.82-1.79],0.3462175065052314
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23317,676,1.02 [0.90-1.15],0.8036361753557842
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23417,351,1.02 [0.86-1.21],0.7865307152873999
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23376,180,0.81 [0.63-1.03],0.0897018693368535
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22489,38,1.06 [0.63-1.77],0.8394736218636962
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22492,41,1.60 [1.00-2.54],0.048080270974986
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22512,61,0.88 [0.58-1.34],0.5557016254382751
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23381,609,1.00 [0.88-1.14],0.9909241351895036
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22923,151,0.83 [0.63-1.08],0.158467056613422
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22694,53,1.10 [0.72-1.70],0.6540671439819562
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23150,84,0.98 [0.69-1.39],0.9218247542886296
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23342,276,1.06 [0.87-1.28],0.583188979329776
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22824,183,0.86 [0.68-1.09],0.2107018789234679
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23312,116,0.77 [0.57-1.05],0.0973371907532472
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23169,397,1.04 [0.88-1.22],0.6451520039073532
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22985,135,1.01 [0.77-1.33],0.946559521111244
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,21921,2165,1.05 [0.98-1.12],0.1747821364476312
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23308,242,1.09 [0.89-1.33],0.4291121978074493
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23433,139,1.24 [0.96-1.61],0.101546713088169
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22785,334,1.06 [0.89-1.26],0.5258562222349658
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23121,55,0.92 [0.59-1.42],0.7000307404373705
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23430,49,1.44 [0.94-2.22],0.0920326360620188
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22532,81,0.79 [0.55-1.14],0.2101172748122464
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22579,128,0.96 [0.73-1.28],0.7993806710772883
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22498,87,1.37 [0.99-1.89],0.0613672383137633
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22695,54,1.04 [0.68-1.60],0.8425470009608305
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22465,54,0.90 [0.58-1.40],0.6453854042424813
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22872,100,0.95 [0.69-1.32],0.772031115486551
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22928,156,0.98 [0.76-1.27],0.8946653111083078
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22562,111,1.10 [0.81-1.48],0.5515266294280401
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22491,80,1.33 [0.95-1.86],0.095849495275664
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22467,56,1.07 [0.70-1.63],0.769718215313578
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,21539,1783,0.99 [0.91-1.06],0.7263490067741365
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22528,77,1.07 [0.75-1.53],0.7154259377433474
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23225,375,1.00 [0.85-1.18],0.9536119400293378
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22889,39,0.80 [0.47-1.36],0.4127867692254762
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22998,148,1.25 [0.97-1.61],0.0824867074842298
PMM2,Phosphomannomutase 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23237,99,0.74 [0.53-1.03],0.0747663629240747
PMM2,Phosphomannomutase 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23415,94,0.70 [0.49-0.98],0.0386799505331429
PMM2,Phosphomannomutase 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23351,122,0.87 [0.65-1.16],0.3470698078434834
PMM2,Phosphomannomutase 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23200,62,0.86 [0.57-1.30],0.4640125292858633
PMM2,Phosphomannomutase 2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23203,65,0.95 [0.64-1.42],0.8061328871480992
PMM2,Phosphomannomutase 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23364,680,0.98 [0.86-1.10],0.6953920811617936
PMM2,Phosphomannomutase 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23150,466,1.03 [0.89-1.20],0.6749201912997791
PMM2,Phosphomannomutase 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22784,100,0.89 [0.64-1.23],0.4891305289946948
PMM2,Phosphomannomutase 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22756,72,0.91 [0.63-1.34],0.6465318480885158
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,23212,75,0.71 [0.49-1.04],0.0812847968098788
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23343,206,0.94 [0.75-1.18],0.6038591214505686
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23192,55,1.16 [0.76-1.75],0.4985877842034267
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,All influenza,22017,108,1.19 [0.88-1.61],0.2648041470195253
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22016,107,1.22 [0.90-1.65],0.2056691881502623
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),16685,111,1.18 [0.88-1.59],0.2656948528472139
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,23331,242,1.14 [0.94-1.39],0.1890775553205932
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18210,1792,1.02 [0.94-1.10],0.6216899716989042
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18345,1771,1.02 [0.95-1.10],0.5775062186548858
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23107,114,1.10 [0.82-1.48],0.5090683259011084
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",21970,61,1.40 [0.95-2.06],0.0934554801450676
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Bronchiectasis,20256,345,1.26 [1.07-1.49],0.0061948095896857
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",19968,57,1.30 [0.87-1.96],0.1985691099349196
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22470,2559,1.06 [0.99-1.12],0.0940804333134256
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22359,56,0.99 [0.65-1.52],0.9786252405291752
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22426,123,1.30 [0.99-1.71],0.0618724325278036
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23306,886,1.14 [1.02-1.26],0.0160172038977586
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22368,65,1.22 [0.84-1.79],0.3002209709790998
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21658,4386,1.06 [1.01-1.11],0.0136043848126402
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22596,293,1.09 [0.90-1.30],0.3767696350302756
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Early onset COPD,22692,272,1.21 [1.00-1.46],0.0445575830720344
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Emphysema,20139,228,1.49 [1.22-1.80],5.908595970276745e-05
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22017,197,1.03 [0.82-1.29],0.811117637184588
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23284,1375,1.06 [0.98-1.16],0.1632798613738903
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22051,231,1.04 [0.85-1.29],0.6901554258927136
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Later onset COPD,22664,614,1.12 [0.99-1.27],0.082820143075364
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23449,180,1.11 [0.88-1.40],0.3843745358963069
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Nasal polyp,22361,58,1.22 [0.82-1.83],0.3292124387017581
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23255,793,1.05 [0.93-1.17],0.4283271562132755
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,23294,1479,1.06 [0.97-1.15],0.1846355600257049
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22976,673,1.18 [1.04-1.32],0.0079693533919674
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Other pleural conditions,21849,34,0.63 [0.36-1.12],0.1172406710375514
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23381,293,1.05 [0.87-1.26],0.6393620083582241
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23379,1005,1.05 [0.95-1.17],0.2995387692154747
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Pleural effusion,22518,703,1.07 [0.95-1.21],0.2436498705637407
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Pleural plaque,21856,41,1.24 [0.76-2.01],0.3886152348964782
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23076,1167,1.06 [0.97-1.17],0.2034833268172367
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23424,155,1.08 [0.83-1.39],0.5693400207374401
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Pneumothorax,21901,86,1.09 [0.77-1.52],0.6318686742999449
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Pollen allergy,23430,203,1.10 [0.89-1.37],0.3862941084456784
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,23142,54,0.82 [0.52-1.28],0.3735585423339799
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,16618,44,1.25 [0.78-2.01],0.3544715968044446
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23236,774,1.03 [0.92-1.16],0.5684005988395178
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22545,242,1.15 [0.94-1.40],0.1715330661499009
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Viral pneumonia,22091,182,1.16 [0.92-1.47],0.2007111483630614
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23116,145,1.11 [0.85-1.44],0.4309088870804012
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11308,89,1.08 [0.76-1.52],0.6693230000258827
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16779,36,1.45 [0.87-2.40],0.1527303788470245
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Acute appendicitis,23289,120,0.72 [0.54-0.98],0.0360714419840523
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Acute gastritis,17614,72,1.10 [0.76-1.59],0.6274775910096224
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,21502,140,1.24 [0.95-1.61],0.1070628188495381
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Acute peritonitis,22973,73,1.29 [0.90-1.85],0.1656861933874185
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22714,30,0.93 [0.52-1.68],0.8107008800684237
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,17839,297,1.15 [0.96-1.38],0.1300726752089931
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21430,68,1.43 [0.99-2.07],0.0554483270673364
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23104,68,1.44 [1.00-2.07],0.0532040493913592
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Cholecystitis,21515,153,1.06 [0.82-1.37],0.6422739516076785
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Cholelithiasis,22385,1023,1.04 [0.94-1.15],0.4249267178950948
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Chronic gastritis,17831,289,1.15 [0.95-1.38],0.1436294921689658
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21395,33,0.95 [0.54-1.66],0.8581148207749905
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23388,63,0.71 [0.46-1.08],0.1062735755961211
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Coeliac disease,22144,128,1.38 [1.06-1.80],0.0184079630117384
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Collagenous colitis,21838,95,0.98 [0.70-1.36],0.8946030865495397
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23333,134,1.01 [0.77-1.33],0.9538789679727248
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Constipation,23166,1453,0.97 [0.89-1.06],0.4785677279276951
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Crohn disease,21812,69,1.35 [0.94-1.94],0.1057682482712087
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23154,49,1.41 [0.92-2.17],0.1156051649698566
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21816,73,1.32 [0.92-1.88],0.1296697309927034
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Dental caries,22750,202,1.02 [0.82-1.27],0.8553604281106917
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22058,2092,1.05 [0.98-1.13],0.146596832662649
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Diseases of appendix,23327,158,0.89 [0.69-1.14],0.3524299861897911
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Diseases of liver,23372,688,0.98 [0.87-1.11],0.759148625706861
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21490,3948,1.02 [0.97-1.07],0.5003190389957399
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23060,512,1.08 [0.94-1.24],0.2868847435455282
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23350,450,1.08 [0.93-1.25],0.3115552274032317
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22649,101,1.00 [0.73-1.37],0.9945548972020324
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22521,55,1.03 [0.67-1.58],0.8948263103508587
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23203,1187,1.05 [0.96-1.15],0.2969517899149378
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Diseases of tongue,22526,89,1.16 [0.84-1.61],0.3733643407594226
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22723,1361,1.11 [1.02-1.21],0.0185770146974716
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19480,2737,1.04 [0.98-1.10],0.2263912921092837
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,17658,116,1.06 [0.79-1.42],0.7101569939164815
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23408,96,1.00 [0.72-1.39],0.9829623160162054
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23369,57,1.40 [0.95-2.08],0.0903730122296317
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22764,80,0.85 [0.59-1.23],0.3845122862371702
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16841,98,1.10 [0.80-1.51],0.5623171808774505
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,18114,572,1.09 [0.95-1.24],0.2134194651121232
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Gastric ulcer,17839,297,0.89 [0.73-1.07],0.2190197671394536
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19929,2387,1.04 [0.97-1.11],0.2694061792581612
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,17951,409,0.96 [0.82-1.13],0.6410818883500791
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18365,7206,1.04 [1.01-1.08],0.0233160234444814
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,GI-bleeding,22959,943,1.01 [0.91-1.12],0.7958935152311766
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22610,62,1.31 [0.89-1.92],0.1762178904033058
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17577,1084,1.12 [1.02-1.24],0.0166353784036118
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22716,32,0.82 [0.46-1.46],0.4988437100150461
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Hernia,22432,2466,1.04 [0.98-1.11],0.2077752253147316
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Impacted teeth,23377,52,1.56 [1.05-2.34],0.0289743596172056
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Impaction of intestines,16801,58,1.33 [0.88-2.00],0.170422727220963
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Inguinal hernia,20115,149,1.08 [0.83-1.40],0.5551110986228788
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16829,86,1.07 [0.76-1.51],0.7014520203264418
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22170,154,1.27 [0.99-1.62],0.0597902075737097
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17435,692,1.12 [0.99-1.26],0.0624092903608037
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23445,297,1.05 [0.87-1.26],0.5936763945435228
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22447,704,1.21 [1.07-1.36],0.0016596655207344
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22683,940,1.20 [1.09-1.33],0.0003979810788175
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17674,132,1.13 [0.86-1.49],0.3735977171166098
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Oesophagitis,18032,490,1.08 [0.94-1.25],0.2701394135323841
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23418,139,1.08 [0.83-1.41],0.5805705733178264
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20017,51,1.20 [0.78-1.86],0.406800974361
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17826,1083,1.02 [0.93-1.13],0.6645406428290128
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21611,249,1.17 [0.96-1.42],0.1259073952390847
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21521,159,0.96 [0.74-1.23],0.7311057096148361
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,18101,1358,1.04 [0.95-1.13],0.4027435451861358
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,21606,4863,1.03 [0.98-1.08],0.2058773436598638
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22531,200,1.03 [0.82-1.29],0.7883289421786189
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other diseases of liver,23258,574,0.98 [0.86-1.12],0.7500397624529888
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18050,508,1.06 [0.92-1.22],0.4278637293508057
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21493,131,1.06 [0.80-1.40],0.6834613103558349
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23293,393,1.06 [0.90-1.24],0.5021541506958266
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18475,933,0.99 [0.89-1.10],0.8172170999715179
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22975,959,1.02 [0.92-1.13],0.7487419709888155
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22700,152,1.07 [0.83-1.38],0.5935162645370602
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18245,1502,0.99 [0.91-1.07],0.7684588624857053
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19334,1792,0.96 [0.89-1.04],0.3354838172967153
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22772,88,0.87 [0.62-1.23],0.4363151165679099
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22577,834,1.17 [1.05-1.30],0.0053036562296024
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17026,283,1.13 [0.94-1.36],0.2008086301074775
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23361,66,1.31 [0.91-1.90],0.1459363517584144
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17167,424,1.07 [0.92-1.25],0.3946092039493353
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22134,118,1.00 [0.75-1.34],0.9869167855037928
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23447,64,0.99 [0.66-1.47],0.9487703476448912
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22550,116,1.05 [0.78-1.40],0.7623348092202338
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Toxic colitis,21797,54,0.98 [0.63-1.52],0.92431213898484
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17749,207,1.14 [0.91-1.42],0.2485783312073838
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,21880,137,1.47 [1.14-1.89],0.0031458594856693
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21856,113,1.49 [1.13-1.98],0.0048973783116271
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Umbilical hernia,20113,147,0.80 [0.61-1.05],0.1040739176210744
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16906,163,0.92 [0.72-1.19],0.5419142142025413
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Ventral hernia,20178,212,1.09 [0.88-1.35],0.4410049078047542
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Volvulus,16816,73,0.99 [0.68-1.44],0.9617309225914058
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23381,214,1.17 [0.95-1.45],0.1473876691589145
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23176,73,0.87 [0.60-1.27],0.4802341974290033
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21712,193,0.92 [0.73-1.15],0.4592441772564021
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22992,540,1.03 [0.90-1.18],0.6746136521019324
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22580,128,1.11 [0.84-1.47],0.4471137322640353
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21786,267,0.95 [0.78-1.15],0.577203154848539
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23183,243,1.01 [0.83-1.24],0.9020239035356944
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23357,417,1.00 [0.85-1.17],0.9802221831459532
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22982,42,1.02 [0.63-1.67],0.9277286096413888
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22078,2701,1.02 [0.96-1.08],0.5176205063571105
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23068,403,0.95 [0.81-1.12],0.54030810809064
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22941,276,0.97 [0.80-1.18],0.779529096606689
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23179,727,1.00 [0.89-1.13],0.9987146081273884
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23436,67,1.06 [0.72-1.56],0.7690734422880348
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21605,86,0.83 [0.58-1.18],0.2989537905982239
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22705,40,1.30 [0.80-2.09],0.2854153211575769
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23169,229,1.01 [0.82-1.24],0.9398288343565984
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21875,356,1.14 [0.97-1.34],0.1227129848467953
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21565,46,0.89 [0.55-1.44],0.6374131785126549
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23369,68,0.69 [0.46-1.03],0.0696563614745719
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22581,129,0.94 [0.71-1.25],0.6840213050494699
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23250,147,0.67 [0.51-0.88],0.0040150104567987
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22982,42,1.23 [0.76-2.00],0.3929707387190735
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21573,54,0.90 [0.58-1.40],0.6500741379398364
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22870,1351,1.02 [0.94-1.11],0.6140956939686673
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21906,387,1.13 [0.97-1.33],0.1265159953185647
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21567,48,0.99 [0.63-1.57],0.9756472096849484
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23380,277,0.83 [0.68-1.01],0.0615322611070446
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23014,74,0.75 [0.51-1.10],0.135826762779572
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23316,213,0.77 [0.62-0.97],0.0241129141765947
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23407,240,1.13 [0.92-1.38],0.242456152911315
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21660,141,0.93 [0.71-1.21],0.5723167676427265
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21742,223,1.00 [0.80-1.23],0.9742600197470304
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23396,229,1.12 [0.91-1.38],0.2733354162962702
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21686,167,1.19 [0.93-1.51],0.1661500383625188
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23426,125,0.78 [0.58-1.05],0.1058772831464436
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20014,112,1.04 [0.77-1.39],0.8172851537873909
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21302,5467,0.99 [0.95-1.04],0.766743463653256
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20124,4289,1.00 [0.95-1.05],0.9669754385168708
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,19967,65,0.88 [0.59-1.32],0.5465551000767993
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20128,133,1.05 [0.80-1.38],0.7303149652156578
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20177,182,1.08 [0.85-1.36],0.5253265965361802
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23213,98,0.79 [0.56-1.09],0.1528465345070779
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20096,101,0.89 [0.64-1.23],0.4812308404562099
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17027,1192,0.99 [0.90-1.09],0.8116658827948737
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23319,198,0.95 [0.75-1.19],0.6516276770272234
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20496,501,1.11 [0.96-1.27],0.1595863680578818
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19703,6946,1.01 [0.98-1.05],0.4918082839214168
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21025,114,0.93 [0.69-1.26],0.6400183183613615
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20016,114,1.16 [0.86-1.55],0.3264336131256313
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20494,592,0.98 [0.86-1.12],0.7650315126509968
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22575,2580,1.05 [0.98-1.11],0.1558471786332252
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20057,155,0.90 [0.69-1.16],0.4191915894814393
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20236,334,1.14 [0.96-1.35],0.1290947651752903
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20051,149,1.09 [0.84-1.41],0.5224250997019539
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22605,95,0.89 [0.64-1.24],0.4861594678108654
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17458,1623,1.01 [0.93-1.10],0.7729305095852882
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16015,180,0.95 [0.75-1.22],0.7046952455412683
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23443,177,0.95 [0.75-1.22],0.697892034317135
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,15925,90,1.05 [0.75-1.47],0.7737049042847755
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16329,494,0.80 [0.69-0.93],0.0039392888480205
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20192,290,0.94 [0.78-1.14],0.5390294721833602
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16388,553,0.99 [0.86-1.13],0.8914234626956712
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20053,58,1.54 [1.05-2.28],0.0289313466392285
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20612,617,1.08 [0.95-1.22],0.2520749040992278
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20284,289,0.94 [0.78-1.13],0.5066634382099994
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16349,514,1.00 [0.87-1.15],0.974892346406828
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,19975,73,1.48 [1.04-2.10],0.0279747747048251
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",19962,60,0.95 [0.63-1.43],0.7946374358947877
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20953,42,1.33 [0.83-2.12],0.2404495658613704
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23051,2140,1.02 [0.95-1.09],0.6431862365379881
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22456,1545,1.04 [0.96-1.13],0.3397441803432733
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23274,503,1.09 [0.95-1.26],0.2147357399212546
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18447,2612,1.00 [0.94-1.06],0.9152468448722656
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,15896,61,0.81 [0.54-1.23],0.3248161790247531
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,19991,89,1.08 [0.77-1.51],0.6513810312274582
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,15877,42,1.21 [0.74-1.98],0.4499347486940008
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16009,174,1.09 [0.86-1.39],0.468930085843512
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21163,252,0.92 [0.75-1.13],0.4390098168106492
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21394,483,0.97 [0.83-1.12],0.6420970804530584
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23431,93,1.12 [0.81-1.56],0.4779276963812192
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21745,1750,1.05 [0.97-1.13],0.2533199960352002
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20014,112,0.87 [0.64-1.18],0.3736072987929395
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16034,199,0.69 [0.54-0.87],0.0019779430214756
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20696,701,0.96 [0.85-1.08],0.4921190900856288
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18023,2188,0.98 [0.92-1.05],0.6067212031851423
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22625,115,0.94 [0.70-1.28],0.7095018434586627
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23437,72,1.06 [0.73-1.53],0.767788495721668
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19967,65,1.00 [0.68-1.49],0.9839666406743938
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21168,1266,1.05 [0.96-1.15],0.2649358341208713
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,19970,68,1.17 [0.80-1.72],0.4042749910324321
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,17541,1706,1.07 [0.99-1.15],0.1020479787623412
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21034,123,1.01 [0.76-1.35],0.9220023082987884
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,19951,49,0.92 [0.58-1.45],0.7059587081575927
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20164,169,0.94 [0.74-1.21],0.6411151540480837
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20392,490,1.01 [0.87-1.17],0.887126445336495
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22955,445,1.19 [1.03-1.38],0.0207995159255635
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20551,556,1.05 [0.92-1.20],0.4852684188665788
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23286,486,1.10 [0.96-1.27],0.1742961482502028
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23433,58,1.24 [0.82-1.85],0.3043068977626325
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20096,194,0.99 [0.79-1.25],0.943327695154458
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17957,782,1.01 [0.90-1.14],0.8222030590439493
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20472,570,0.97 [0.85-1.11],0.6556619878178922
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20008,106,0.97 [0.71-1.33],0.8599149214040552
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",15906,71,1.10 [0.76-1.61],0.6161251923891662
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18097,2262,1.06 [0.99-1.13],0.0969549091814319
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16557,722,1.07 [0.95-1.21],0.2329377778045895
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22764,254,1.23 [1.01-1.50],0.035137708507422
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23405,67,1.11 [0.76-1.63],0.5908638804399562
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21480,47,1.05 [0.66-1.67],0.8255339403375983
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,15908,73,1.02 [0.70-1.49],0.9003090538443154
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20089,94,0.86 [0.62-1.21],0.3859852813345124
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16342,507,1.09 [0.94-1.25],0.2445620822751744
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20179,277,0.79 [0.65-0.96],0.0202780827466488
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20242,247,1.25 [1.02-1.52],0.0275005621041961
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20233,238,1.06 [0.86-1.30],0.5780656891389143
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18074,75,1.28 [0.90-1.82],0.1763890101790034
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23438,63,1.12 [0.76-1.66],0.5706212692352828
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20448,546,0.98 [0.86-1.13],0.8100967899583282
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],22655,145,1.04 [0.80-1.36],0.7489465619315939
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22323,2421,1.02 [0.96-1.09],0.5310305758805907
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20036,134,0.80 [0.60-1.06],0.1219613435836796
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20478,483,1.08 [0.93-1.25],0.3088151317131478
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,21955,218,0.92 [0.74-1.15],0.4726832510099129
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20208,213,1.09 [0.88-1.36],0.4127040843829402
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21480,1485,0.99 [0.91-1.07],0.7911549456826967
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21006,1011,0.99 [0.90-1.10],0.8680063635400547
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],19957,55,0.89 [0.58-1.38],0.608303563058558
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22716,206,1.05 [0.84-1.31],0.6529734602453419
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20073,171,0.88 [0.68-1.12],0.2973249681177334
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20016,114,0.83 [0.61-1.13],0.2310399139161423
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),15877,42,1.44 [0.90-2.31],0.1291396048739883
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22627,1026,1.06 [0.96-1.18],0.2227801203451061
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17527,85,1.24 [0.89-1.73],0.1955935531249979
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,22857,97,1.01 [0.74-1.39],0.9340889451382012
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23323,199,1.26 [1.01-1.56],0.0402502433206132
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23147,23,0.67 [0.33-1.36],0.2707832838277063
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22745,1144,1.01 [0.92-1.11],0.7961456986045627
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23316,58,0.85 [0.55-1.31],0.4614053394789923
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23290,198,0.94 [0.75-1.19],0.6213747601125091
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Cystitis,20714,213,0.95 [0.76-1.18],0.6288145641848673
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Dialysis,21646,45,1.36 [0.86-2.13],0.1879019328292968
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23040,280,1.01 [0.84-1.22],0.910301732235248
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,17590,148,1.18 [0.91-1.52],0.2048523027702354
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",17776,334,0.88 [0.74-1.05],0.1568875102183083
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18302,860,1.11 [1.00-1.23],0.0584583840485384
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18201,4230,1.06 [1.01-1.11],0.027814828112467
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23309,51,1.15 [0.75-1.78],0.5202524552325493
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,21486,176,0.89 [0.70-1.14],0.3625383701614284
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,22978,339,1.03 [0.87-1.22],0.7176193231140469
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,23056,107,0.65 [0.47-0.90],0.0095131568704661
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,17705,263,1.12 [0.93-1.36],0.2397474479992428
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20568,67,1.06 [0.72-1.56],0.7586326173015497
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19514,2072,1.04 [0.97-1.12],0.2663618745049702
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17557,115,1.34 [1.01-1.77],0.0410821079640615
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23446,56,1.02 [0.67-1.56],0.9198700609736988
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23446,65,0.89 [0.59-1.33],0.5639322116485715
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22381,1880,1.08 [1.00-1.16],0.048409250605
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20907,406,0.98 [0.83-1.14],0.7618406576441876
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,22858,98,0.93 [0.68-1.29],0.6793917165376024
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23407,315,1.14 [0.96-1.36],0.1361299705831211
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23405,76,1.21 [0.85-1.72],0.2976344177647814
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22106,1605,1.10 [1.02-1.19],0.0193841951591699
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,22814,175,1.09 [0.86-1.38],0.4784256366472371
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17577,135,1.14 [0.87-1.50],0.3336446507076417
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17773,331,0.98 [0.82-1.17],0.8404014526250272
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17539,97,1.09 [0.79-1.50],0.6115631713301558
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17616,174,1.16 [0.92-1.47],0.2180630913736156
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21529,219,1.01 [0.81-1.25],0.9470023952791286
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23194,102,1.33 [0.99-1.80],0.0617286094202994
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17702,260,1.17 [0.96-1.42],0.1116620607304112
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17532,90,1.16 [0.84-1.61],0.3671864893895199
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,17979,537,0.99 [0.87-1.14],0.9183515141233348
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17579,137,1.37 [1.05-1.77],0.0190089892575186
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,17937,495,0.93 [0.81-1.08],0.3545341599994656
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23292,34,1.08 [0.63-1.86],0.7718446975432969
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23308,1998,1.03 [0.96-1.10],0.4762760106520627
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",21453,143,1.15 [0.89-1.49],0.2967807448248897
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21678,77,1.15 [0.80-1.64],0.4528289386143721
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23155,31,1.61 [0.96-2.72],0.0728835098033955
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20627,126,1.28 [0.97-1.68],0.0801519946371162
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23353,229,1.26 [1.03-1.55],0.0237226555055493
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17560,118,1.21 [0.91-1.60],0.1964600341413682
